News for 'Consumer Healthcare'

Dabur's robust India biz showing lifts shares

Dabur's robust India biz showing lifts shares

Rediff.com9 May 2026

Dabur India's shares rose 3.7 per cent after reporting in-line Q4FY26 results, driven by a healthy 10 per cent growth in its India business, despite some analysts remaining cautious about future execution.

Smallcap Schemes Lead Mutual Fund Rally

Smallcap Schemes Lead Mutual Fund Rally

Rediff.com1 Jun 2026

Most actively-managed equity mutual fund schemes outperformed their benchmarks despite volatility across domestic equity markets during the past year.

'Market Has Become Excessively Bearish On India'

'Market Has Become Excessively Bearish On India'

Rediff.com11 Jun 2026

'When I look at India's relative valuations, these are by far the lowest I have seen in my 35-year career.' 'The relative 12-month trailing performance is among the weakest I have seen, and foreign investor positioning is at a 16-17 year low.'

Bihar government drops Sanjay Gandhi's name from Patna zoo, dairy institute

Bihar government drops Sanjay Gandhi's name from Patna zoo, dairy institute

Rediff.com30 Apr 2026

The Bihar government, led by Chief Minister Samrat Choudhary, has renamed the Sanjay Gandhi Biological Park as 'Patna Zoo' and the Sanjay Gandhi Institute of Dairy Technology as 'Bihar State Institute of Dairy Technology'. The cabinet also approved significant allocations for electricity subsidies, college establishments, and infrastructure projects.

Osmania Hospital Suicide: Probe Launched After Medical Student's Death

Osmania Hospital Suicide: Probe Launched After Medical Student's Death

Rediff.com16 Apr 2026

A postgraduate medical student allegedly died by suicide in his hostel room at Osmania General Hospital in Hyderabad, prompting a police investigation and protests over work pressure.

DII holdings in Nifty 500 hit record 20.9%, FPIs' slid to a new low in Q4

DII holdings in Nifty 500 hit record 20.9%, FPIs' slid to a new low in Q4

Rediff.com13 May 2026

Domestic Institutional Investors (DIIs) have significantly increased their holdings in Nifty 500 companies, reaching a record 20.9 per cent by the end of March, while Foreign Portfolio Investors (FPIs) reduced their ownership to an all-time low of 17.1 per cent, according to Motilal Oswal Financial Services.

Higher input costs, price hikes may play spoilsport for HUL

Higher input costs, price hikes may play spoilsport for HUL

Rediff.com12 May 2026

Hindustan Unilever (HUL) exceeded consensus estimates in Q4FY26, driven by lower overheads and 6 per cent consolidated volume growth. However, the company anticipates further price hikes to counter an expected 8-10 per cent material cost inflation, while maintaining a mid-term margin guidance of 22.5-23.5 per cent.

Near-term growth, margin triggers missing in Wipro's Q4 results

Near-term growth, margin triggers missing in Wipro's Q4 results

Rediff.com26 Apr 2026

Wipro reported Q4FY26 IT services revenue of $2.6 billion, a modest 0.2 per cent Q-o-Q constant currency growth, with adjusted operating profit margin beating estimates at 17.2 per cent. The company announced a significant share buyback of ~15,000 crore, but faces near-term growth challenges, particularly in the BFSI segment, and has issued a soft Q1FY27 revenue guidance.

How Krutrim Became India's First AI Unicorn

How Krutrim Became India's First AI Unicorn

Rediff.com5 May 2026

Krutrim, India's first AI unicorn, has successfully repositioned itself as a focused domestic AI Cloud Services provider, reporting its first annual net profit in FY26.

India Adopts Balanced AI Regulatory Approach

India Adopts Balanced AI Regulatory Approach

Rediff.com3 Mar 2026

An Indian AI Research Organisation official says India has adopted a balanced and pragmatic approach to AI regulation, avoiding the extremes of the US and EU models.

Dabur faces a tangle of growth headwinds

Dabur faces a tangle of growth headwinds

Rediff.com23 Apr 2026

Dabur India's stock has fallen over 17 per cent since the start of the Iran war, driven by concerns over a weak monsoon, the West Asian crisis, and rising input costs, which are expected to impact the company's revenues and margins, particularly affecting its significant rural sales and international markets.

FMCG firms expect high single-digit growth in Q4FY26

FMCG firms expect high single-digit growth in Q4FY26

Rediff.com4 Apr 2026

Fast-moving consumer goods (FMCG) companies like Dabur India and Marico anticipate high single-digit growth in Q4FY26, driven by strong domestic demand in India, which is helping to offset the negative impact of geopolitical conflicts in West Asia on their international businesses.

Health Expert Cautions Against AI Self-Diagnosis

Health Expert Cautions Against AI Self-Diagnosis

Rediff.com27 Feb 2026

A senior health expert warns against the growing trend of using AI for self-diagnosis and treatment, emphasizing that these tools should not replace human clinical judgment.

Nomura, Citi slash year-end Nifty 50 target

Nomura, Citi slash year-end Nifty 50 target

Rediff.com17 Mar 2026

Foreign brokerages have started to cut their year-end targets for the Nifty 50 index amid the ongoing West Asia conflict.

Stock Market Today: Sensex, Nifty50 Surge as US-Iran Tensions Ease

Stock Market Today: Sensex, Nifty50 Surge as US-Iran Tensions Ease

Rediff.com1 Apr 2026

Indian markets on Dalal Street rallied sharply as easing tensions in the US-Iran conflict and stable oil prices boosted sentiment. Track Nifty 50 and BSE Sensex performance and key global triggers.

Gulf War: Stocks That Tanked The Most

Gulf War: Stocks That Tanked The Most

Rediff.com14 Apr 2026

West Asia conflict triggers sharp sell-off in Indian markets, with realty, banking and auto stocks leading losses amid energy shock fears.

57% Americans disapprove of Trump's performance: Poll

57% Americans disapprove of Trump's performance: Poll

Rediff.com5 Mar 2026

A new poll indicates that President Donald Trump's approval rating is suffering as economic anxieties and the rising cost of living weigh heavily on US voters, revealing deep political divides and widespread dissatisfaction with the government.

Gulf War: Stocks That Could Buck The Trend And Shine

Gulf War: Stocks That Could Buck The Trend And Shine

Rediff.com14 Apr 2026

10 stocks from the Nifty 200 index that offer good growth potential and scope to deliver decent returns from current levels, based on brokerage estimates.

Wipro's $1 bn Olam deal, Mindsprint acquisition marks major strategic win

Wipro's $1 bn Olam deal, Mindsprint acquisition marks major strategic win

Rediff.com7 Apr 2026

Wipro, India's fourth-largest IT services company, has secured an eight-year deal with Singapore-based Olam group, valued at over $1 billion, and will also acquire Olam's IT and digital services arm, Mindsprint, for $375 million, marking one of its largest contracts to date.

India expands PNG network; rolls out 2.7L new connections in Mar

India expands PNG network; rolls out 2.7L new connections in Mar

Rediff.com31 Mar 2026

India significantly increased piped natural gas (PNG) connections in March as the government accelerates the expansion of cleaner fuel networks amid global supply disruptions.

Hyderabad claims its place as global MNC destination

Hyderabad claims its place as global MNC destination

Rediff.com18 Feb 2026

Hyderabad is rapidly emerging as a strategic hub for multinational companies (MNCs) deepening their focus on artificial intelligence (AI), life sciences, and global capability centres (GCCs), supported by the city's strong pharmaceutical (pharma) base, deeptech talent pool, and a policy environment that encourages high-value investment.

AI scare triggers worst FPI fortnightly exit from IT stocks since July 2025

AI scare triggers worst FPI fortnightly exit from IT stocks since July 2025

Rediff.com20 Feb 2026

Fears around artificial intelligence (AI) sparked a global selloff in information technology (IT) stocks, dragging down domestic software shares and prompting the heaviest foreign portfolio investor (FPI) outflows since the second half of July 2025.

Under 40 Founders Power Rs 31 Trillion

Under 40 Founders Power Rs 31 Trillion

Rediff.com30 Jan 2026

Interestingly, with 83 per cent of entrepreneurs being first-generation founders, the list reflects India's growing spirit of entrepreneurship and leadership.

AI ecosystem opaque, needs accountability: CCI chairperson

AI ecosystem opaque, needs accountability: CCI chairperson

Rediff.com26 Feb 2026

The artificial intelligence (AI) ecosystem is opaque and needs to be made transparent and accountable, said Competition Commission of India's (CCI) Chairperson Ravneet Kaur at the Business Standard Manthan Summit on Wednesday.

10 Stocks That May Gain From Budget

10 Stocks That May Gain From Budget

Rediff.com4 Feb 2026

The fiscal tilt towards capex benefits companies in investment-related sectors like capital goods, defence equipment, engineering & construction and metal & mining. The planned cut in revenue expenditure will weigh on companies in consumption sectors like FMCG, consumer durables and retail.

Growth triggers missing in Dabur

Growth triggers missing in Dabur

Rediff.com14 Jan 2026

Dabur's business update for Q3FY26 indicated mid-single digit consolidated revenue growth. The guidance is that growth in operating and net profits will beat revenue growth. In the domestic business, home and personal care (HPC) revenue grew in double digits, while healthcare is likely to post a sequential growth in low-single digits.

Which Sectors Bore FPI Brunt In 2025?

Which Sectors Bore FPI Brunt In 2025?

Rediff.com23 Jan 2026

FPIs net sold equities worth Rs 1.7 trillion in 2025 -- the highest annual net sale on record.

Mankind Pharma sees 21% profit surge in Q2 despite consumer health hurdles

Mankind Pharma sees 21% profit surge in Q2 despite consumer health hurdles

Rediff.com20 Nov 2023

Pharmaceuticals major Mankind Pharma reported a 21 per cent year-on-year (Y-o-Y) increase in net profit, with revenue rising by 12 per cent Y-o-Y in the second quarter of the financial year 2024 (Q2FY24) in a regulatory filing lrecently.

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Rediff.com11 Mar 2026

For decades, multinational pharmaceutical companies and Indian drugmakers worked in ways that supported each other: MNCs brought innovation and brands, while Indian companies built scale through generics and cost efficiency. There was an important overlap - generic drugs - but this is shrinking fast. And the consequences are reshaping India's gigantic pharmaceutical market.

Jharkhand air ambulance crash: DGCA begins probe

Jharkhand air ambulance crash: DGCA begins probe

Rediff.com25 Feb 2026

The Directorate General of Civil Aviation (DGCA) has launched an investigation into the air ambulance crash in Jharkhand's Chatra district that killed all seven people on board. Two teams from the DGCA are probing the accident, while families mourn the loss of their loved ones.

Open offers highest since 2008 as acquisition, takeover attempts surge

Open offers highest since 2008 as acquisition, takeover attempts surge

Rediff.com29 Dec 2025

Open offers this calendar year, following attempts at acquisition and takeover, came in at more than two a week. There were 121 such open offers to acquire additional shares following a substantial acquisition or change of control, shows the data compiled by primedatabase.com.

Ahead of IPO, Practo eyes $1 bn GMV

Ahead of IPO, Practo eyes $1 bn GMV

Rediff.com30 Dec 2025

Digital healthcare platform Practo is targeting annualised gross merchandise value (GMV) of $1 billion by June 2026, with its expanding US operations expected to contribute between $250 million and $300 million, according to people familiar with the company's plans.

Seniors to Drive 25% of India's Pharma

Seniors to Drive 25% of India's Pharma

Rediff.com21 Nov 2025

'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going to dominate the market for the next several decades.'

Tamil Nadu bets big on India's first full-stack sovereign AI park

Tamil Nadu bets big on India's first full-stack sovereign AI park

Rediff.com14 Jan 2026

The sovereign AI park will be a first-of-its-kind, purpose-built district in India, integrating AI compute infrastructure, secure data frameworks, model research labs, and AI innovation clusters, along with a dedicated institute for AI in governance.

Women Power India's Retail Push

Women Power India's Retail Push

Rediff.com5 Jan 2026

'It's harder to attract women initially, but once they come in, retention is significantly higher.'

India terms EU envoys' article unusual before key Putin visit

India terms EU envoys' article unusual before key Putin visit

Rediff.com3 Dec 2025

India and Russia are poised to sign multiple agreements to bolster cooperation in various sectors, including trade and healthcare, during Russian President Vladimir Putin's visit to New Delhi. Discussions will also address the Ukraine conflict and efforts to increase Indian exports to Russia.

Global Investing: What YOU Must Know

Global Investing: What YOU Must Know

Rediff.com16 Oct 2025

Here's what Indian investors diversifying into equities, ETFs, and real estate abroad to manage risk, returns, and currency exposure must watch out for.

How To Deal with Medical Negligence

How To Deal with Medical Negligence

Rediff.com10 Oct 2025

Medical negligence arises when a medical professional deviates from reasonable standards of care, causing injury to the patient.

Don't Let Your Health Cover Fall Short

Don't Let Your Health Cover Fall Short

Rediff.com6 Jan 2026

With medical inflation hovering at around 13-14 per cent annually, policyholders must reassess their sum insured once every two years.

Pan masala cess to boost public health, security

Pan masala cess to boost public health, security

Rediff.com8 Dec 2025

Experts said that earmarking of funds for public health at par with national security indicates a key policy shift.